Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2026-01-08 @ 3:36 AM
Study NCT ID:
NCT03575234
Status:
WITHDRAWN
Last Update Posted:
2019-08-28
First Post:
2018-06-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal Cancer
Sponsor:
Emory University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-01-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-01-31
Completion Date Type:
ESTIMATED
First Submit Date:
2018-06-21
First Submit QC Date:
None
Study First Post Date:
2018-07-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-08-26
Last Update Post Date:
2019-08-28
Last Update Post Date Type:
ACTUAL